Amicus Therapeutics to Present at Upcoming Investor Conferences
March 02 2017 - 7:30AM
Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company
at the forefront of therapies for rare and orphan diseases, today
announced that management will present at two upcoming investor
conferences.
John Crowley, Chairman and Chief Executive
Officer, will present at the Cowen & Company 37th Annual Health
Care Conference in Boston, MA on Wednesday, March 8, 2017 at 9:20
a.m. ET.
Chip Baird, Chief Financial Officer, will
present at the Barclays Global Healthcare Conference 2017 in Miami,
FL on Tuesday, March 14, 2017 at 11:15 a.m. E.T.
A live webcast of both presentations can be
accessed through the Investors section of the Amicus Therapeutics
corporate web site at
http://ir.amicustherapeutics.com/events.cfm, and will be
archived for 90 days.
About Amicus Therapeutics Amicus Therapeutics
(Nasdaq:FOLD) is a biotechnology company at the forefront of
therapies for rare and orphan diseases. The Company has a robust
pipeline of advanced therapies for a broad range of human genetic
diseases. Amicus’ lead programs in development include the small
molecule pharmacological chaperone migalastat as a monotherapy for
Fabry disease, SD-101 for Epidermolysis Bullosa (EB), as well as
novel enzyme replacement therapy (ERT) and biologic products for
Fabry disease, Pompe disease, and other rare and devastating
diseases.
CONTACTS:
Investors/Media:
Amicus Therapeutics
Sara Pellegrino
Senior Director, Investor Relations
spellegrino@amicusrx.com
(609) 662-5044
Media:
MWW PR
Sid Dinsay
sdinsay@mww.com
(646) 381-9017
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Apr 2023 to Apr 2024